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Evidence of Early-Stage Selection 
on EPAS1 and GPR126 Genes in 
Andean High Altitude Populations
Christina A. Eichstaedt  1,2, Luca Pagani3,4, Tiago Antao5, Charlotte E. Inchley3, Alexia 
Cardona6, Alexander Mörseburg3, Florian J. Clemente7, Timothy J. Sluckin  8, Ene 
Metspalu4,9, Mario Mitt10,11, Reedik Mägi10, Georgi Hudjashov4,12, Mait Metspalu4,9, Maru 
Mormina13, Guy S. Jacobs14 & Toomas Kivisild3,4
The aim of this study is to identify genetic variants that harbour signatures of recent positive selection 
and may facilitate physiological adaptations to hypobaric hypoxia. To achieve this, we conducted whole 
genome sequencing and lung function tests in 19 Argentinean highlanders (>3500 m) comparing them 
to 16 Native American lowlanders. We developed a new statistical procedure using a combination 
of population branch statistics (PBS) and number of segregating sites by length (nSL) to detect 
beneficial alleles that arose since the settlement of the Andes and are currently present in 15–50% of 
the population. We identified two missense variants as significant targets of selection. One of these 
variants, located within the GPR126 gene, has been previously associated with the forced expiratory 
volume/forced vital capacity ratio. The other novel missense variant mapped to the EPAS1 gene 
encoding the hypoxia inducible factor 2α. EPAS1 is known to be the major selection candidate gene 
in Tibetans. The derived allele of GPR126 is associated with lung function in our sample of highlanders 
(p < 0.05). These variants may contribute to the physiological adaptations to hypobaric hypoxia, 
possibly by altering lung function. The new statistical approach might be a useful tool to detect selected 
variants in population studies.
High altitude represents an extreme environment characterised by low concentrations of atmospheric oxygen 
(hypoxia), arid climate, high solar radiation and other environmental stressors. Populations have resided at high 
elevations in Ethiopia, the Himalayas and the Andes for several millennia1. Each of these populations, faced with 
ongoing environmental pressure, has developed their unique array of physiological adaptations. In Andeans, 
these include an enlarged chest, increased lung capacities2, only slightly increased ventilation rate and an elevated 
haematocrit3.
In this study we focus on the Colla population living in the Northwest Argentinean highlands. Collas also 
inhabit Southern Bolivia and Northern Chile and are considered to be related to other Andean groups such as 
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Quechua, Aymara and Atacameño4. These groups could trace back to the beginning of human settlement in the 
Andes, which archaeological evidence places between 12,000 and 9,000 years before present5–7.
The genetic component of high altitude adaptation in Andeans has been the subject of a number of recent 
studies8–10. Using genotype data genes such as VEGFB, PRKAA1, NOS2A and FAM213A have been suggested 
to be under selection in Andeans8–10. These genes play a role in a vast array of processes such as cardiac func-
tion, oxygen sensing, vasodilation and oxidative stress reduction. In Tibetans, a particular gene involved in the 
response to hypoxia, the hypoxia inducible factor 2α (HIF-2α) or EPAS1, has been repeatedly shown to have a 
signature of selection11–14 and to be associated with the almost absent increase of haemoglobin concentration 
in native Himalayan populations11,14. A gene involved in the oxygen sensitive expression of HIF itself, EGLN1, 
was selected in both Tibetans and Andeans12. A first subset of Andean whole genome sequences was published 
comparing 10 healthy Peruvian highlanders with highlanders suffering from chronic mountain sickness15. The 
authors detected variants in an erythropoiesis regulator gene SENP1, and an oncogene, ANP32D in association 
with cross-population tests of selection and a higher transcriptional response to hypoxia in individuals with 
chronic mountain sickness relative to those without.
Compared to other high altitude populations, such as Tibetans, Andeans have been living for less time at ele-
vations above 3500 m. Given that there has been shorter duration for selection to act, rather than being close to 
fixation, it is likely that proportionally more advantageous gene variants exist at intermediate frequencies. To this 
end, we complement the scans for hard sweep variants with scans for signatures of incomplete selective processes. 
These tests are applied on high coverage whole genome sequence data for healthy Andean highlanders from 
Northwest Argentina together with sequence data from Native American lowlanders and pinpoint to variants 
advantageous in the adaptation to high altitude.
Results
The sequencing of the whole genome of 19 Collas living above 3500 m resulted in an average genome-wide call 
rate of 97.4% (min. 97.1%). Coverage of 30x was reached for 95% of the genome with a minimum of 89% in one 
individual, while the minimum exonic coverage was 93%. On average 280 Gb of sequence data could be mapped 
for each genome with a minimum of 205 Gb in a single individual. Around 3.3 million SNPs could be identified 
in each highlander genome. Of these 1.7% were novel SNPs. Within the whole exome only 20,900 SNPs were 
identified with 2% representing newly discovered SNPs (on average for each individual per genome compared 
to a reference genome). About 10,200 synonymous SNPs had no effect on the amino acid sequence while 9,350 
were non-synonymous. These were further classified as: mainly missense mutations (9,250, average value of all 
individuals), about 75 nonsense, 10 nonstop, 18 misstart and 70 disruptive mutations.
To investigate population structure, effective population size and split times of highlanders and control pop-
ulations in the last 300,000 years we conducted multiple sequentially Markovian coalescent analyses (MSMC, 
Fig. 1). All non-African populations showed a similar pattern 30,000–300,000 years ago dominated by the out of 
Africa exit. Split dates of non-African populations were around 12,000–30,000 years. Population divergence was 
consistent with a single Eurasian origin for all analysed populations. The neighbouring populations Collas and 
Calchaquíes only separated in the last 5,000 years (Fig. 1). Calchaquíes showed high genetic similarity but also 
population specific differences to the Collas2. The divergence time of Collas and lowland Wichí was estimated to 
be 5,000 years possibly indicating the onset of permanent high altitude settlement (Fig. 1). The genetic effective 
population size of Collas declined to 1500 around 9000 years ago and then rose up to 30,000 at 3,000 years ago. 
The total census size in 2005 of the Collas was estimated to be around 70,500 including Collas residing at lower 
altitudes16.
Signals for positive selection in Collas. We first searched for alleles with high-frequency differences 
between Collas and other populations that could be driving late-stage selective sweeps. We retrieved all SNPs 
located in top 1% Tajima’s D17 and number of segregating sites by length (nSL)18 200 kb windows, and then filtered 
these for variants in the top 1% of population branch statistic (PBS)14 scores. PBS is a statistic that detects variants 
that have changed substantially in frequency in a target population, using a related population and an outgroup 
to determine which population the allele frequency change occurred in. The nSL test is a haplotype based statistic 
identifying haplotypes that are at high frequency but haven’t yet been broken up by recombination, suggesting 
that the increase in frequency was recent. Both statistics seek to identify a recent change in the frequency of an 
allele or haplotype, which can reflect the impact of selection in a genomic region. PBS was calculated for 19 Collas 
in comparison to 19 Siberians19,20 and 16 lowlanders from Central and South America2. The lowland group rep-
resented a conservative grouping since it included Calchaquíes, who live at an altitude of 2300 m in Argentina 
and bear overall genomic similarities to the nearby Collas2. Hence, any genomic signatures shared by Calchaquíes 
and Collas would be missed by our approach. These filters yielded 72 SNPs. After excluding SNPs with frequency 
>10% in the 1000 Genomes database, those without gene annotation, and with combined annotation dependent 
depletion (CADD) scores ≤5 only 9 SNPs remained (Table 1).
All of these SNPs were highlighted by the haplotype test nSL and none by Tajima’s D. Notably, six of the nine 
remaining SNPs were found in the same haplotype context located on chromosome 11 at 67 Mb. Interestingly, this 
region is 3 Mb upstream of the highest ranking region highlighted previously by the integrated haplotype score 
(iHS) test in Collas9. The SNP with the highest CADD score of 19.11 was part of the ANKRD13D gene which 
codes for an ubiquitin binding protein. All hits were in non-coding regions and also showed substantial allele 
frequency in the lowland population (Table 1).
Given the short time-frame of human occupation in the Andes21, we hypothesize that ongoing selective 
sweeps acting on intermediate frequency selected variants may contribute a substantial fraction of adaptive 
genetic changes among the Collas. However, detecting a selective sweep in its early stages poses particular chal-
lenges. When selection has not yet driven an allele to high frequency, the impact on linked genetic variation is 
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also low. Consequently, most statistics designed to detect positive selection only have high power towards the 
final stages of a selective sweep22–24. Using simulations to inform our targeted approach, we chose to combine 
several aspects of the population genetic data and genome annotation information. To search for these signals, 
we focused on derived allele frequency (DAF) ≥ 15% and ≤50% to identify alleles at the beginning of selection 
which are overlooked in the traditional positive selection tests. To this end, we obtained population branch statis-
tic (PBS) and number of segregating sites by length (nSL) scores for exonic variants with a DAF ≥ 15% and ≤50% 
in Collas, corresponding to 17147 SNPs of which 2831 (16.5%) were classified as missense variants in dbSNP 
build 141. Calculating nSL + PBS scores as described in the methods (Fig. 2a) yielded a similar score distribution 
as retrieved from simulations (Fig. 2b); these simulations further suggested that combining the two methods 
results in a greater power to identify intermediate frequency sweeps than each method on its own (Fig. 2c). This 
approach yielded 42 missense hits (Supplementary Table S1), as compared to the 28 expected missense SNPs (sig-
nificant enrichment, corrected Chi Square test, one-sided p = 0.0023). PBS, nSL, and p(PBS|DAFColla) statistics 
used alone yielded 25, 31 and 31 hits respectively (one-sided p-value not significant). Assuming missense variants 
are more likely to have an adaptive phenotypic effect, the data supports simulations in suggesting that combining 
Figure 1. MSMC plot, effective population sizes and split times of Collas, Native American lowlanders, 
Siberians and Africans. Effective population size (Ne) and split time estimates are based on 1, 2 or 4 genomes 
for the Native Americans and on 2 and 4 genomes for the other populations. Coloured dots show where the 
MSMC curves based on 1, 2 or 4 genomes were joined together to provide a comprehensive representation of 
the changes in Ne over time for each of the analysed population. Around 100,000 years the out of Africa exit 
starts to reduce population size in non-Africans. Yoruba show a limited decline as they remain in Africa. Ne of 
Collas rises up to 30,000 units 3,000 years ago. Andean highlanders: Collas; Calchaquíes (Cachi): intermediate 
altitude population in Argentina (2300 m); American lowlanders: Mexican, Wichí; Siberians: Eskimo, Koryaks, 
Chukchi.
Chr: position Identifier
Allele 
frequency 
Collas
Allele 
frequency 
Lowlanders
Allele 
frequency 
Siberians
1000 
Genomes 
DAF Impact Associated gene
PBS 
p-value
11:67209515 rs111451405 74% 44% 3% 4% syn CORO1B 0.001
11:67072382 rs61731786 71% 44% 3% 7% syn SSH3 0.002
11:67076748 rs12417770 71% 44% 3% 7% intronic SSH3 0.002
11:67159257 rs17880138 71% 44% 3% 7% promoter RAD9A 0.002
11:67165015 rs2066494 71% 44% 3% 6% syn RAD9A 0.002
11:67057599 rs1574103 71% 47% 3% 4% syn ANKRD13D 0.005
6:159062992 rs882735 63% 38% 0% 2% intronic DYNLT1 0.006
20:2840929 rs2297048 58% 25% 18% 4% syn VPS16 0.008
20:2844911 rs2274671 58% 25% 18% 5% syn PTPRA; VPS16 0.008
Table 1. Top 1% PBS alleles located within top 1% nSL windows. Chr = chromosome, DAF = derived allele 
frequency, syn = synonymous; CADD score for all SNPs > 5.
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p(PBS|DAFColla) and nSL scores increases power to detect early-stage selection. Based on the degree of enrich-
ment, we expect approximately 14/42 top missense hits to be caused by non-neutral processes.
We found that 23/42 (54.8%) missense hits had evidence of a deleterious effect (as indicated by a deleteri-
ous SIFT or PolyPhen2 categorisation), compared to 960/2733 (35.1%) over all scored missense variants. This 
enrichment (corrected Chi-Square, one-sided p-value = 0.0066) suggests that PBS + nSL outliers are likely to be 
damaging. Given that we would expect 42 * 0.344 ≈ 14.7 damaging hits in 42 random missense variants, finding 
23 suggests an excess 8–9 damaging missense variants that may be non-neutral.
The enrichment of selection signatures among deleterious missense variants with outlier PBS + nSL scores 
prompted us to define a set of variants with especially high-probability of being damaging. We supplemented 
SIFT and PolyPhen2 scores with CADD scores for our 42 missense hits and defined a high-probability damaging 
variants as (SIFT: “damaging”, PolyPhen2: “possibly damaging” or “probably damaging”, and CADD Phred >5). 
This identified 11 SNPs (Table 2).
Of these 11 SNPs, two (rs570553380 and rs543290190) are not found in 1000 Genome Phase 1 data and are 
polymorphic only in Peruvians from Lima in the extended 1000 Genome Phase 3 data set; this was only true for 
one other variant in our list of 42 missense hits. Tellingly, one of these two variants (rs570553380) is located in 
the EPAS1 gene, which is a major oxygen sensor and has been identified multiple times as subject to high alti-
tude selection in Tibetans11–14. The other SNP (rs543290190) is located in AKAP6, which is involved in cardiac 
myocyte reaction to stresses such as hypoxia, hypertrophic remodelling of the heart25 and stabilises the hypoxia 
master regulator HIF-1α during hypoxia while enhancing its degradation at normoxia26. Furthermore, of the 
11 shortlisted SNPs, rs17280293, located in GPR126, is the variant with the second most extreme nSL + PBS 
score. During the course of our data analysis, a study of a European cohort was published identifying a strong 
association between lung function and SNP rs148274477 (largest effect size and most extreme p-value reported 
in that study, p = 9.58e−26)27. In that cohort, the GPR126 SNP rs17280293 that we identify here is mentioned as 
being in strong LD with rs148274477 (r2 = 0.85). While the same level of LD is observed in our Colla population 
(r2 = 0.848) the intriguing possibility exists that it, rather than rs148274477, is driving a strong lung function 
association in a population unrelated to the Colla. The derived alleles at both SNPs in GPR126 rs148274477 
and rs17280293 are associated with increased forced expiratory volume in the first second/forced vital capacity 
(FEV1/FVC). As we have FEV1/FVC measurements for our 19 Colla individuals2, we were able to speculatively 
test for a similar association in our small Colla sample. We could identify a positive association (Fig. 3; one-tailed 
p = 0.029) with each additional derived allele at rs17280293 associated with an increase in FEV1/FVC of 0.075 
(standard error = 0.037). While this association does not persist when phenotypic and genetic data from Wichí 
(a lowland population) and Calchaquíes (an intermediate altitude population) are incorporated into the linear 
regression (one-tailed p = 0.158, data not shown) there could be several confounding factors such as population 
Figure 2. Distribution of nSL + PBS and power calculations. (a) Observed joint distribution of nSL and 
p(PBS|DAF) of all exonic SNPs (blue), with top-1% outliers coloured teal (not missense), orange (missense) 
or red with black border (missense; the 11 highly damaging variants). (b) Simulated joint distribution of nSL 
and p(PBS|DAF), with X- and Y-axes as in (a). Results from neutral scenarios are shown in blue, with those 
from selected scenarios (s = 0.02) in red. Note the clustering of selected SNPs in the low-p(PBS|DAF), low-nSL 
regime, corresponding to that detected by our PBS + nSL selection statistic; also note the especial clustering of 
most damaging missense variants in (a) in this region of the plot. (c) Power from the simulations of the three 
statistics to detect selection, with selected variants with a p-value ≤ 0.0062 classified as successful detections. X- 
and Y-axes are derived allele frequency and power, respectively.
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structure or an effect on FEV1/FVC associated with the altitude at which the lung function measurements were 
taken.
Based on a wide range of evidence - low worldwide frequency DAF (1000 Genome) and local population dif-
ferentiation (PBS), relatively extended derived-allele haplotype homozygosity (nSL) and evidence for disruption 
of the protein (SIFT, PolyPhen2, CADD) – as well as evidence based on prior selection signals and gene function, 
we consider the two missense variants in EPAS1 and GPR126 as high-probability selection candidates.
Discussion
In this study, we have detected missense variants as novel candidates for local positive selection in the genomes 
of Andean highlanders with possible functional consequences. By combining different selection statistics, along 
with genome annotation information, we were able to identify intermediate frequency variants that may contrib-
ute to high altitude adaptation in two very prominent candidate genes, GPR126 and EPAS1. The first gene has 
been previously associated with lung function measurements; the second, with the main adaptive phenotype in 
Tibetans. In contrast, no functional variant could be identified in Collas by scans of late-stage selective sweeps.
Our first main finding is the second strongest hit in the intermediate frequency analysis originated from a 
missense SNP (rs17280293) in GPR126 (or ADGRG6, Adhesion G Protein-Coupled Receptor G6) found at 2.8% in 
1000 Genomes Project data. This mutation causes an amino acid change (p.S123G) classed as damaging by SIFT 
and possibly damaging by PolyPhen2 within the seven transmembrane domain of the protein. Several previous 
studies have shown a strong association of this gene with lung function27,28. Furthermore, this SNP has been 
identified as in strong linkage disequilibrium with a variant (rs148274477) associated with FEV1/FVC. We found 
Chr: Position Identifiera Ref Alt
Allele 
frequency 
Collas
Allele 
frequency 
Lowlanders
Allele 
frequency 
Siberians
1000 
Genomes 
DAF Gene
Amino 
acid 
change
PBS + nSL 
score
8:24349417 rs3736281 T C 47% 6% 11% 2.8% ADAM7 I453T 0.000
6:142688969 rs17280293 A G 50% 3% 8% 2.8% GPR126 S123G 0.000
21:33689199 rs762225 G C 34% 3% 5% 1.4% URB1 P2071R 0.001
1:40766943 rs140041506 G T 37% 6% 5% 0.7% COL9A2 P661T 0.001
14:58958923 rs3783697 A G 29% 6% 32% 2.4% KIAA0586 D1263G 0.001
14:33165230 rs543290190 T C 16% 0% 0% 0.1%b AKAP6 W972R 0.002
3:77629200 rs188582283 C T 24% 0% 0% 0.9% ROBO2 R811W 0.002
2:46588031 rs570553380 A G 32% 6% 0% 0.2%c EPAS1 H194R 0.004
6:76631823 rs76604824 C T 24% 3% 3% 4.6% IMPG1 D793N 0.004
22:30888494 rs17738527 C T 50% 16% 0% 14.4% SEC. 14L4 E211K 0.005
16:3708170 rs2791 C T 24% 0% 0% 1.7% TRAP1 R692H 0.006
Table 2. Top PBS + nSL missense hits based on intermediate derived allele frequencies between 15–50%. aAll 
variants were classed as possibly/probably damaging in PolyPhen 2 and damaging in SIFT and had a CADD 
score > 17, for values see Supplementary Table S1. bOnly found in 4 heterozygote Peruvians from Lima out of 85 
individuals. cOnly found in 12 heterozygote Peruvians from Lima out of 85 individuals; lowland allele frequency 
strongly influenced by 20% allele frequency in Calchaquíes (n = 2). Chr = chromosome, Ref = reference allele, 
Alt = alternative allele, DAF = derived allele frequency.
Figure 3. FEV1/FVC in Collas sorted by derived allele frequency. The ratio increases with number of derived 
alleles indicating an improvement of lung function in Collas. One-tailed p-value = 0.029, r2 = 0.195; FEV1: 
forced expiratory volume in the first second, FVC: forced vital capacity.
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rs17280293 to be associated with FEV1/FVC in our own phenotype data, suggesting that Andeans with a derived 
allele may have better equipped lungs for life at high altitude. This is the first time a phenotype in Andeans could 
be correlated with genomic data. Taken together, the extreme PBS + nSL score, evidence of damaging effect, and 
association with lung function situate rs17280293 as an interesting selection candidate.
Our second main finding highlighted a missense SNP in the hypoxia inducible factor 2 α (HIF-2α, EPAS1) 
at intermediate frequencies in the Collas. While the HIF-1α is activated during short-term hypoxia, HIF-2α is 
rather expressed as a chronic hypoxia response29. Both transcription factors regulate a plethora of genes involved 
in energy metabolism and differential oxygen use during hypoxic conditions. EPAS1 has already been repeat-
edly shown to have a signature of selection in Tibetan populations11–14,30, but this is the first study to indicate 
selection also in Andeans. Since this gene was highlighted with a test investigating variants at intermediate lev-
els it may indicate that a potentially advantageous allele of EPAS1 is on its way to higher frequencies also in 
Andeans but has not yet reached levels equivalent to Tibetans. Interestingly, the selected haplotype in Sherpas 
and Tibetans was suggested to be an introgression from the Denisovan genome31 and its frequency increased 
with altitude of populations in the Himalayas32. The Tibetan genotype has been associated with an inhibition of 
haemoglobin concentrations rise at high altitude11,14. However, the specific functional mechanism has not yet 
been identified in Tibetans. This might be due to the fact that all highlighted SNPs so far fall within non-coding 
regions of the gene33. In contrast, the highlighted variant in Andeans (rs570553380) encodes a missense muta-
tion predicted to have a damaging effect on protein function. Knock-out studies in mice underlined the essen-
tial role of HIF-2α for normal erythropoiesis. Complete knock-out leads to a drastically reduced haematocrit34. 
Heterozygous knock-out mice had a similar haematocrit compared to wild type mice but showed a resistance to 
hypoxia induced pulmonary hypertension and thus no subsequent right ventricular hypertrophy35. This func-
tional advantage under hypoxic conditions suggests a protective role of at least some loss of function mutations 
in EPAS1 for life at high altitude. In contrast, human patients with gain of function mutations were characterised 
by pulmonary hypertension and erythrocytosis showing a continuous activation of the HIF response36. Hypoxia 
induced pulmonary hypertension is a universal physiological response to lowlanders going to high altitude37 and 
is constantly present in Andeans38. While in healthy highlanders pressures are only moderately increased39 they 
are exaggerated in individuals suffering from chronic mountain sickness, which is more common in the Andean 
population than in other high altitude dwellers40. Pulmonary hypertension leads to a remodelling of the pul-
monary vasculature, inducing changes which may result in right heart failure. Thus, a protective allele in EPAS1 
might not only reduce the red blood cell count as seen in Tibetans but also protect from extensive pulmonary 
hypertension in the Andean population.
We based our results on 19 whole genome sequences from the Argentinean Collas. The results of this study 
should be confirmed in a larger sample possibly including further Andean high altitude populations. Additionally, 
further work to clarify the effect of the EPAS1 variant, for example by assessing any association with haematocrit 
in these groups, would be valuable.
In conclusion, we introduce a new approach for detecting early-stage selective sweeps which enables us to 
identify moderate frequency (0.15–0.50) derived variants in Andean high altitude populations as potential targets 
of recent selection. Among exonic variants with functional annotation we identify two missense variants in the 
GPR126 and EPAS1 genes. GPR126 is known to be involved in lung function and the selected EPAS1 variant might 
have a potential protective effect on hypoxia induced erythrocytosis and pulmonary hypertension. In case of the 
EPAS1 gene, our results are the first to point to a plausible target of selection at variant level. Considering this var-
iant is restricted to South America these results provide strong evidence of convergent evolution in Andeans and 
Tibetans living with the same environmental pressures on opposite sides of the world. The approach of detecting 
early-stage selective sweeps has the potential to be applied to other cases of recent local selection.
Methods
Subjects and ethical approval. All participants provided their written informed consent. The study was 
approved by the by the Ethics Committee at the University of East Anglia and the Ministry of Health of the 
Province of Salta (Ministerio de Salud Pública, Salta, Argentina). Ethical approval for the whole genome sequenc-
ing of the samples was obtained from University of Cambridge Human Biology Research Ethics Committee 
(HBREC.2011.01). All methods were performed in accordance with the relevant guidelines and regulations. High 
altitude samples were collected from an Andean population, the Colla, living in Northern Argentina at an altitude 
>3500 m9. Native American lowland control samples for selection analyses originated from 5 Calchaquí and 4 
Wichí from neighbouring regions in Argentina2, plus publicly available sequences from the Complete Genomics 
database including 5 Mexican (NA19648-200-37-ASM, NA19669-200-37-ASM, NA19735-200-37-ASM, 
NA19649-200-37-ASM, NA19670-200-37-ASM) and 2 Puerto Rican (HG00732-200-37-ASM, GS000015711-
ASM) samples20. Additional North-East Siberian samples served as controls for threesided population statistics 
including 2 Chukchi, 4 Eskimo and 13 Koryak individuals19,20. Two additional Chukchi individuals were added 
in the demographic analyses.
Whole genome sequences. Whole genome sequences were obtained with the Complete Genomics 
platform and quality filtered as described elsewhere20. The newly sequenced Colla genomes were deposited in 
the European Nucleotide Archive: PRJEB14828. Data are also freely available through the Estonian Biocentre 
website. All genomes were annotated against the Ensembl GRCh37 database and compared to dbSNP Human 
Build 141 and Phase 1 of the 1000 Genomes Project dataset41 as described previously20. For 1000 Genomes var-
iant frequency Phase 3 data42 was used. We focused on variants annotated as “exonic” in Ensembl occurring in 
Hardy-Weinberg equilibrium in our sample resulting in 402,227 autosomal variants. Variants with a combined 
annotation dependent depletion (CADD) score >5 were investigated further. The CADD score was calculated to 
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estimate impact of synonymous and non-synonymous variable alike43. Missense variants were assessed with the 
in silico prediction programs SIFT44 and Polyphen245.
Tests of positive selection. Two statistics were calculated for each SNP – the population branch statistic 
(PBS)14 and the number of segregating sites by length (nSL)18. The PBS score was based on pairwise FST values 
for the three populations using a weighted analysis of variance46 with the program GENEPOP’00747. PBS was 
estimated as in Yi and colleagues14. The nSL scores were calculated only on the Colla sample.
Two statistics were window based. We calculated Tajima’s D on the Colla sample using non-overlapping 200 kb 
windows17. A window-based nSL score was also calculated as the average proportion of common (minor allele 
frequency < 95%) SNPs with |nSL| > 2.0 in a 200 kb window.
In scans for late-stage hard sweeps we first identified the 200 kb windows that showed genome-wide the lowest 
1% of Tajima’s D or nSL scores. The top 1% PBS scoring variants in these windows were further filtered for SNPs 
with less than 10% frequency in the 1000 Genomes Phase 3 data. We only retained those with a CADD score 
higher than 5.
Intermediate frequency based selection. As the timescale of human occupation of the Andes is rela-
tively short21, we supplemented our selection scans with an attempt to detect positive selection acting on interme-
diate frequency variants. To this end, we first chose to focus on SNP-by-SNP selection statistics, considering each 
SNP a potential target of selection. Although this vastly increases the number of tests we performed, early-stage 
selective sweeps have not yet had a substantial impact on variation far from the selected locus such that they may 
be difficult to detect using average statistic values or the number of outliers over large genomic windows. We 
first calculated the two statistics PBS and nSL for each SNP in the Colla sample. For nSL approximate p-values 
were generated, based on nSL scores that were standardised in derived allele frequency (DAF) bins assuming 
unstandardised SL follows a roughly normal distribution in frequency bins. PBS values were calculated using 
lowland Americans as the comparative closely related control population and Siberian populations as outgroup. 
These were then converted into empirical p-values given DAF in Collas based on 4% DAF bins (e.g. if a PBS value 
for the 15% ≤ DAFColla < 19% bin is the 990th largest of 1000 values, its p(PBS|DAFColla) would be 0.01). nSL has 
been shown to have power to detect early-stage selective sweeps18, while PBS has been an effective test-statistic for 
detecting local selection. Simulations suggest that combining these two statistics using Fisher’s method provides 
a composite statistic with high power to detect early-stage sweeps (see Fig. 2).
To reduce the number of hypothesis tests and focus on variants for which annotation information exists, we 
cut our Fisher-combined PBS + nSL score data to SNPs in the exome (Ensemble Biomart B37Rel75), and only 
considered SNPs with DAF in the Colla of 15% ≤ DAF ≤ 50% to focus on early-stage selective sweeps. We consid-
ered the set of top 1% most extreme statistic value SNPs as enriched for SNPs subject to or impacted by selection. 
We filtered this set for missense variants and obtained CADD, SIFT and Polyphen2 scores for each SNP.
Multiple sequentially Markovian coalescent analyses. Effective population sizes (Ne) and population 
split times between Collas and other Native Americans were estimated using multiple sequentially Markovian 
coalescent model (MSMC)48 on up to four phased genomes per population, as described elsewhere20. To provide 
a comprehensive picture of the changes in effective population size over time of each of the analysed populations, 
the MSMC curves obtained using 1, 2 or 4 genomes were joined together at points of their overlap. The joining 
was performed to maximise the MSMC accuracy within a given time interval, as suggested by Schiffels and 
Durbin48 and implemented by Clemente, Cardona and colleagues49.
Simulations. Simulations were performed using the forward-time population genetic simulator SLiM50. 
Briefly, we generated a null distribution of nSL, p(PBS|DAF) and the combined nSL + PBS statistic by generating 
250 neutral simulations of the Koryak, Wichí and Colla populations, taking population sizes and population split 
times from our MSMC analysis. Here, the Colla and Wichí split 5478 years before present (ybp), and the Koryak 
and ancestral Wichí/Colla population 19451 ybp. These split times are inferred based on cross-coalescence, and 
no migration is included in the model. We assumed a generation time of 25 years, and started the model at 1 
million years ago (with a short, 500-generation burn-in). In each simulation, we generated 1 MB of genetic data, 
using a mutation rate of 1.7e−8/generation and human-realistic variable recombination rate by randomly sam-
pling from non-centromeric regions of the chromosome 2 of the HapMap combined genetic map51. At the end of 
each simulation we retrieved samples according to our study (38 Colla chromosomes, 32 Wichí and 38 Koryak), 
and then randomly chose 50 mutations with DAF 0.15–0.75 in the Colla sample from the central region (450 
kb-550 kb) of the data. We calculated SL and PBS for each of these mutations.
To approximate the distribution of these statistics under selection, we performed 160 simulations follow-
ing the neutral model until the time of the Colla/Wichí split. At this point, for 20 times in each replicate, we 
randomly chose a variant in the central region (450 kb-550 kb) and applied positive selection (heterozygote 
s = 0.01, homozygote derived s = 0.02) for the next 5478 years in the Colla population. We restarted any of the 20 
‘sub-replicate’ routines if the selected allele did not have 0.15 ≤ DAF ≤ 0.75 at sampling time in the Colla sample. 
On successful completion of a sub-replicate, SL and PBS were calculated for the selected variant.
For both neutral and selected results, SL was normalised to nSL and PBS to p(PBS|DAF) using 5% frequency 
bins and the neutral distribution of SL and PBS. The nSL score was converted to an approximate p-value by 
assuming a standard normal distribution of SL in frequency bins, and this was combined with p(PBS|DAF) using 
Fisher’s method. Each frequency bin included at least 440 neutral results and 100 selected results. Power was 
estimated using the Fisher-combined p-values with a p-value cut off of 0.0064 (corresponding to the top-1% 
combined p-value in our genomic data, with weak correlations between nSL and p(PBS|DAF) driving this from 
the expected value of 0.01).
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Genotype-phenotype assessment. Lung function measurements of forced vital capacity (FVC) and 
forced expiratory volume 1 second (FEV1) for Collas were reported previously2. A ratio of FEV1/FVC was calcu-
lated and linear regression was used to assess effects of the derived allele with a one-sided p-value.
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